COVID-19：日本Avegan临床试验，于7月份继续进行：感染人群减少，目标人群短缺
新型冠状病毒肺炎（COVID-19）：新冠肺炎（COVID-19）：COVID-19：
COVID-19治疗候选者，Avigan临床试验：
在六月底，我无法及时赶到
预计将在7月之后继续
原来是6月8日。
这是因为随着被感染人数的减少，临床试验对象的人数正在减少。
FUJIFILM：
据FUJIFILM Holdings称，结束日期尚未确定。
FUJIFILM / Toyama Kagaku最初的时间表是从3月底到6月底，目标是96人参加。
由于COVID-19感染的急剧减少，该计划似乎被推迟了。
将来，我们希望增加接受临床试验的医院数量，并加快早日批准的工作。
https://this.kiji.is/642679958022423649
Fujifilm says COVID-19 drug research may drag on into July
June 7, 2020, 2:24 pm
TOKYO (Reuters) –
Fujifilm Holdings Corp’s research on Avigan as a potential treatment for COVID-19 may drag on until July, the company said on Sunday,
a further setback in the Japanese firm’s race to find a vaccine.
There is a possibility that clinical trials will continue in July, a Fujifilm spokesman said,
responding to a Nikkei report that any approval will be delayed until July or later, due to a lack of patients for trials.
But researchers have only been able to get around 70% of the patients needed for the trials, and because it takes 28 days to get results,
the process will continue until at least July, the Nikkei business daily said, citing an unnamed source.
https://news.yahoo.com/amphtml/fujifilm-says-covid-19-drug-052439601.html